For research use only. We do not sell to patients.

KSI-3716

CAS No. : 1151813-61-4

Biological Activity：KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancer.

Research Area：Cancer

Targets：Autophagy|c-Myc

Related Screening Libraries:Bioactive Compound Library Plus;Apoptosis Compound Library;Anti-Cancer Compound Library;Autophagy Compound Library;Glutamine Metabolism Compound Library;Anti-Cancer Metabolism Compound Library;Transcription Factor-Targeted Library;Targeted Diversity Library;Chemotherapy Drug Library;Anti-Prostate Cancer Compound Library;Cancer Stem Cells Compound Library;

Related Small Molecules:Stauprimide;BTYNB;10074-G5;c-Myc inhibitor 4;10074-A4;CMLD010509;sAJM589;Anticancer agent 84;hnRNPK-IN-1;c-Myc inhibitor 5;IZCZ-3;VPC-70063;EN4;Mollugin;Anticancer agent 76;MYC-IN-2;ML327;MYCi361;FUBP1-IN-2;VPC-70619;IRES-C11;Agrimol B;10058-F4;MYCMI-6;PROTAC BRD4 Degrader-6;APTO-253;Lusianthridin

About Us:

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
Structurally and synthetically diverse biologically active compounds；
roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；

Structurally and synthetically diverse biologically active compounds；

Customized order volume ranging from milligrams to kilograms scale；

We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.

Top Publications Citing Use of MCE Products